USA Risperdal News

USA Risperdal News

Risperdal trials in the U.S. have found that more patients suffer strokes or fatalities when taking Risperdal than those who take a placebo. In some experiments, these consequences are nearly doubled for Risperdal users.

In 2003, Janssen Pharmaceuticals issued a letter to doctors regarding the health risks of Risperdal. One year later, the FDA warned Janssen that this letter was misleading. The Janssen letter did not disclose information about Risperdal’s potential diabetes, coma, and death risks.

The attention Risperdal received in the national news has lead to a number of Risperdal-related lawsuits. Nobody should be deceived by misleading pharmaceutical advertising. It is an irresponsible and callous act when drug manufacturers knowingly market dangerous products. Fortunately, awareness about the negative consequences of Risperdal has been raised among Americans.

  • - -
  • By clicking the "Submit" button below, you agree that law firms you are matched with may contact you by telephone even if you are on a federal or state Do Not Call registry. Up to 10 law firms may respond to your request within approximately 2 weeks. In some cases 3 or more firms may respond to your request after 30 days. Use of this site is subject to our Terms of Use.

Home | Sitemap

Website Design & Web Positioning by Wise Law Group

Copyright ©2012- All rights reserved | Terms of Use

This site is about Risperdal and side effects. We offer a legal guide to help you find a Risperdal lawyer in your area. Please contact us today if you have taken Risperdal and have been injured.